Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Mirati Therapeutics (MRTX)

$96.72 4.55 (4.94%)

17:01 EST MRTX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $96.72

Market Cap 3.12B

PE Ratio -37.74

EPS -2.562953

Volume (Avg. Vol.) 343,400

Day's Range 92.28 - 97.89

52-Week Range 55.11 - 132.59

Dividend & Yield N/A (N/A)

MRTX Stock Predictions, Articles, and Mirati Therapeutics News

From InvestorPlace
From the Web

The 10 Best Stocks for 2019 — So Far

By James Brumley, InvestorPlace Feature Writer Jun 4, 2019

Roku, Array Biopharma and Guardant Health are just some of the best stocks by returns for the first half of 2019.

Best & Worst Performing Mid Cap Stocks for February 18, 2020

From StockNews.com Feb 18, 2020

LM – LM leads the way today as the best performing mid cap stock, closing up 24.41%.

Noteworthy Tuesday Option Activity: HLF, GS, MRTX

From Market News Video Feb 18, 2020

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Herbalife Nutrition Ltd (HLF), where a total of 11,596 contracts have traded so far, representing approximately 1.2 million underlying shares. That amounts to about 103.7% of HLF's average daily trading volume over the past month of 1.1 million shares..

JonesTrading Reiterates a Buy Rating on Mirati Therapeutics (MRTX)

From Analyst Ratings Feb 18, 2020

JonesTrading analyst Soumit Roy reiterated a Buy rating on Mirati Therapeutics (MRTX – Research Report) today. The company’s shares closed last Monday at $92.17. According to TipRanks.com, Roy is a 5-star analyst with an average return of 18.3% and a 46.1% success rate. Roy covers the Healthcare sector, focusing on stocks such as Monopar Therapeutics

MRTX Makes Notable Cross Below Critical Moving Average

From Market News Video Feb 14, 2020

In trading on Friday, shares of Mirati Therapeutics Inc (MRTX) crossed below their 200 day moving average of $92.80, changing hands as low as $91.39 per share. Mirati Therapeutics Inc shares are currently trading down about 2.6% on the day..

Is There An Opportunity With Mirati Therapeutics, Inc.’s (NASDAQ:MRTX) 43% Undervaluation?

From Simply Wall St Feb 7, 2020

How far off is Mirati Therapeutics, Inc. (NASDAQ:MRTX) from its intrinsic value? Using the most recent financial data, we’ll take a look at whether the stock is fairly priced by<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mrtx/mirati-therapeutics/news/is-there-an-opportunity-with-mirati-therapeutics-inc-s-nasdaqmrtx-43-undervaluation/">Read More...</a></div>

Oversold Conditions For Mirati Therapeutics (MRTX)

From Market News Video Jan 31, 2020

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold